Cullinan Therapeutics (CGEM) Prepaid Assets (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly Prepaid Assets came in at $9.5 million in Q1 2026, down 31.72% year-on-year from $13.9 million in Q1 2025, and up 7.47% quarter-over-quarter from $8.9 million in Q4 2025.
Cullinan Therapeutics (CGEM) Prepaid Assets (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 31.72% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 31.72% decrease from a year earlier, with the FY2025 full-year figure at $8.9 million, down 43.53% from the prior year.
- Prepaid Assets advanced to $9.5 million in Q1 2026 per CGEM's latest filing, from $8.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $15.7 million in Q4 2024 and bottomed at $619000.0 in Q3 2022.
- The 5-year median for Prepaid Assets is $9.6 million (2025), against an average of $9.4 million.
- Across the five-year window, Prepaid Assets plunged 94.77% in 2023 and jumped 2372.37% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $7.2 million in 2022, then soared by 82.79% to $13.1 million in 2023, then advanced by 19.56% to $15.7 million in 2024, then tumbled by 43.53% to $8.9 million in 2025, then increased by 7.47% to $9.5 million in 2026.
- Per Business Quant, the three latest CGEM Prepaid Assets figures stand at $9.5 million (Q1 2026), $8.9 million (Q4 2025), and $9.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.52 Mn |
| Dec 31, 2025 | 8.86 Mn |
| Sep 30, 2025 | 9.64 Mn |
| Jun 30, 2025 | 10.43 Mn |
| Mar 31, 2025 | 13.95 Mn |
| Dec 31, 2024 | 15.69 Mn |
| Sep 30, 2024 | 13.96 Mn |
| Jun 30, 2024 | 15.30 Mn |
| Mar 31, 2024 | 12.71 Mn |
| Dec 31, 2023 | 13.12 Mn |
| Sep 30, 2023 | 619,000.00 |
| Jun 30, 2023 | 619,000.00 |
| Mar 31, 2023 | 8.33 Mn |
| Dec 31, 2022 | 7.18 Mn |
| Sep 30, 2022 | 619,000.00 |
| Jun 30, 2022 | 11.85 Mn |
| Mar 31, 2022 | 7.46 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 7.79 Mn |
| Jun 30, 2021 | 7.76 Mn |